Market Place
Sourcing Support
Lilly Joins Wells Fargo`s 20th Annual Healthcare Conference
23 Aug 2025 //
PR NEWSWIRE
Trump Administration Imposes 15% Generic Drug Tariff on EU
22 Aug 2025 //
BIOSPACE
Obesity Drug Heavyweights` Battle
15 Aug 2025 //
FIERCE PHARMA
Lilly Signs $1.3 B Deal with Superluminal for Obesity Medicines
15 Aug 2025 //
REUTERS
Lilly Launches Mounjaro KwikPen (tirzepatide) in India
15 Aug 2025 //
EXPRESSPHARMA
Texas Sues Eli Lilly Over Alleged Kickback Scheme
12 Aug 2025 //
FIERCE PHARMA
Texas Accuses Eli Lilly of Bribing Providers for Prescriptions
12 Aug 2025 //
REUTERS
Obesity Leaders Fortify Injectable GLP-1 Empires With Manufacture
12 Aug 2025 //
BIOSPACE
Lilly, UK Govt Launch £85M Obesity Pathway Innovation Programme
12 Aug 2025 //
PHARMAWEB
Lilly Raise Earning Forecast on Surge Demand of Weight-Loss Drug
08 Aug 2025 //
REUTERS
Eli Lilly Confirms Plan to Sell NJ Plant
05 Aug 2025 //
ENDPOINTS
Mounjaro measures up to Trulicity in Eli Lilly cardio trial
01 Aug 2025 //
FIERCE PHARMA
Obesity Drug Trials Underway in Big and Small Pharma Labs
31 Jul 2025 //
ECONOMICTIMES
Kisunla Shows Greater Benefit in Early Alzheimer’s: 3-Year Data
30 Jul 2025 //
PR NEWSWIRE
Lilly`s BTK Jaypirca Outperforms Imbruvica in Trials
30 Jul 2025 //
FIERCE PHARMA
LTZ Therapeutics, Eli Lilly Collab on Autoimmune Disease Platform
29 Jul 2025 //
BUSINESSWIRE
Lilly Links up With Gate in $856 M Biobucks Deal
26 Jul 2025 //
FIERCE BIOTECH
Lilly`s Kisunla, Gilead`s Pr Ep Drug Yeytuo Gain CHMP Nods
25 Jul 2025 //
FIERCE PHARMA
Donanemab Receives Positive Opinion from CHMP in Early Alzheimer
25 Jul 2025 //
PR NEWSWIRE
Lilly Completes Acquisition of Verve Therapeutics
25 Jul 2025 //
PR NEWSWIRE
Lilly and Verve Confirm End of Verve Tender Offer
24 Jul 2025 //
PR NEWSWIRE
Lilly Sets Date for Q2 2025 Financial Results Announcement
24 Jul 2025 //
PR NEWSWIRE
Study: GLP-1s May Shield Against Neurodegeneration
23 Jul 2025 //
BIOSPACE
Lilly Enlists `happy Gilmore 2` Star as Zepbound Partner
21 Jul 2025 //
FIERCE PHARMA
ET Graphics: Tirzepatide, Semaglutide lead India, misuse concerns
16 Jul 2025 //
ECONOMICTIMES
Lilly and API Launch `Obesity Gurukul` in India
15 Jul 2025 //
INDPHARMAPOST
Illimis Raises $42M Series B for CNS, Immune Drugs
14 Jul 2025 //
PR NEWSWIRE
Lilly Partners with Api to Launch a CME for Obesity
14 Jul 2025 //
EXPRESSPHARMA
Lilly Continues Breast Cancer Detection Push at WNBA All-Stars
14 Jul 2025 //
FIERCE PHARMA
US FDA Approves Gradual Dosing for Lilly Alzheimer`s drug
10 Jul 2025 //
PRESS RELEASE
Lilly’s Biologics Humatrope Receives Suppl Approval in US
09 Jul 2025 //
FDA
Eli Lilly Launches Mounjaro KwikPen for Type 2 Diabetes in India
08 Jul 2025 //
ECONOMICTIMES
Mounjaro Hits Rs 50 Cr Milestone in India as Wegovy Enters Market
08 Jul 2025 //
ECONOMICTIMES
Anti-obesity drug war heats up as Wegovy and Mounjaro boost sales
07 Jul 2025 //
BUSINESS STD
Obesity Drugs Shoots up In India as Lilly, Novo for Market Share
07 Jul 2025 //
REUTERS
Delhi Hc Seeks Regulator`s Reply on Ozempic, Mounjaro Nod in Pil
03 Jul 2025 //
ECONOMICTIMES
Eli Lilly`s Biologics Kisunla Receive Suppl Approval in US
01 Jul 2025 //
FDA
Lilly, Innovent`s Mazdutide Nabs First-In-Class Nod in China
28 Jun 2025 //
FIERCE PHARMA
Eli Lilly to roll out diabetes medicine in prefilled pen
27 Jun 2025 //
ECONOMICTIMES
Lilly Declares Third-Quarter 2025 Dividend
23 Jun 2025 //
PR NEWSWIRE
Oral GLP-1 Agonist Orforglipron Shows Strong HbA1c, Weight Loss
23 Jun 2025 //
PR NEWSWIRE
Lilly Says India Response to Obesity Drug Mounjaro Is `positive`
20 Jun 2025 //
REUTERS
Scholar Rock`s Drug Helps Zepbound Patients Retain More Muscle
20 Jun 2025 //
REUTERS
RyboDyn Joins Lilly Labs to Target Dark Proteome Therapies
19 Jun 2025 //
PR NEWSWIRE
Camurus` POSITANO study: CAM2029 effects in liver disease
18 Jun 2025 //
PR NEWSWIRE
Lilly to appeal UK Agency`s Alzheimer`s Drug Reimbursement Denial
18 Jun 2025 //
REUTERS
Eli Lilly nears $1.3 Billion Deal for Verve Therapeutics
17 Jun 2025 //
REUTERS
Eli`s Obesity Drug Shows Over 11% Weight Loss in Early Trial
14 Jun 2025 //
REUTERS
Eli Lilly Works out $650 M Juvena Pact to Muscle-Boosting Drugs
12 Jun 2025 //
FIERCE BIOTECH
Weight-loss drug bulks up sales as patients upgrade dosage
08 Jun 2025 //
ECONOMICTIMES
Welldoc, Lilly Launch Personalized Platform for Incretin Patients
04 Jun 2025 //
BUSINESSWIRE
Haya Therapeutics Moves San Diego Operations to Lilly Gateway Lab
03 Jun 2025 //
BUSINESSWIRE
Camurus, Lilly Ink Deal for Long-Acting FluidCrystal® incretins
03 Jun 2025 //
PR NEWSWIRE
Grünenthal Acquires Cialis Rights from Lilly in Mexico, Brazil
02 Jun 2025 //
PR NEWSWIRE
Lilly presents first clinical data for FR? targeting ADC at 2025
02 Jun 2025 //
PR NEWSWIRE
Lilly to join Goldman Sachs Global Health Care Conference
02 Jun 2025 //
PR NEWSWIRE
Nxera Pharma Hits Milestone with Eli Lilly in Metabolic Diseases
01 Jun 2025 //
GLOBENEWSWIRE
Lilly Reveals Ada 85th Scientific Sessions Presentations
28 May 2025 //
PR NEWSWIRE
Lilly lands next-gen pain asset in $1B SiteOne acquisition
28 May 2025 //
REUTERS
Weight-Loss Drug Discounts Fall Short, Copies Face US Crackdown
23 May 2025 //
REUTERS
